http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111134113-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N53-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N25-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N53-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-04 |
| filingDate | 2019-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111134113-B |
| titleOfInvention | Ethiprole-dicyclopropanate oil suspending agent and preparation method and application thereof |
| abstract | The invention provides an ethiprole-dicyclopropanate oil suspending agent and a preparation method and application thereof, and relates to the technical field of pesticides. The dicyclopropanetin oil suspending agent consists of the following components in percentage by weight: 5-20% of ethiprole, 2-20% of dicyclopropyl, 1-3% of tert-butylhydroquinone, 5-25% of surfactant, 0.1-10% of thickener and solvent for complementing the weight to 100%. The preparation method of the oil suspending agent comprises the following steps: the ethiprole and the dicyclopropanesefat original drug, the tert-butyl hydroquinone, the surfactant, the thickening agent and the solvent are mixed, and the ethiprole and the dicyclopropanesefat oil suspending agent are obtained after sanding and filtering. The oil suspending agent has the advantages of overcoming the technical problem that ethiprole and dicyclopropanate are easy to decompose due to ingenious formula, obviously enhancing the stability, avoiding the defect of excessive medicine loss during medicine application and reducing the medicine application times. |
| priorityDate | 2019-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 37.